ONCOLOGY Nurse Edition October 2008, Vol 22 No 11
October 2008, Vol 22 No 11
Main Articles
Psychological Challenges After Cancer: A Guide for Clinical Practice Reviewed in:
The Recklitis et al Article Reviewed
LATE EFFECTS CLINIC: Post-Trauma Symptoms in Cancer Survivors
Graft-Versus-Host Disease: A Complex Long-Term Side Effect of Hematopoietic Stem Cell Transplant Reviewed in:
The Barton-Burke et al Article Reviewed
DRUG ESSENTIALS: Small Molecule Multitargeted TKI Therapy
PATIENT INFORMATION: Fatigue in People with Cancer
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
